| The timing of 30‐month stay expirations and generic entry: A cohort study of first generics, 2013–2020 S Kannappan, JJ Darrow, AS Kesselheim, RF Beall Clinical and Translational Science 14 (5), 1917-1923, 2021 | 7 | 2021 |
| We need to work differently in a crisis: peer-professional leadership to redesign physicians’ work J Woiceshyn, JL Huq, S Kannappan, G Fabreau, E Minty, S Pendharkar, ... BMJ leader 6 (2), 2022 | 5 | 2022 |
| Development and validation of a 21-gene prognostic signature in neuroblastoma M Gupta, S Kannappan, M Jain, D Douglass, R Shah, P Bose, ... Scientific Reports 13 (1), 12526, 2023 | 2 | 2023 |
| High incidence of hematologic malignancy relapse after allogeneic transplantation in patients with low Epstein-Barr virus–specific T-cell counts M Gupta, S Kannappan, A Kalra, C Lam, P Dharmani-Khan, T Williamson, ... Cytotherapy 21 (8), 886-894, 2019 | 2 | 2019 |
| In vitro investigation demonstrates IGFR/VEGFR receptor cross talk and potential of combined inhibition in pediatric central nervous system atypical teratoid rhabdoid tumors H Obaid, S Kannappan, M Gupta, Y Ruan, C Zhang, P Bose, A Narendran Current Cancer Drug Targets 20 (4), 295-305, 2020 | 1 | 2020 |
| Targeting Oncogenic Polyamines in Refractory Pediatric Leukemias Using the Anti-Protozoan Drug α-Difluoromethylornithine (DFMO) in Combination With GC7 and Aurothioglucose B Hofmann, S Kannappan, G Mehul, C Zhang, S Chi, D Hanson, ... Blood 132, 2725, 2018 | 1 | 2018 |
| Digital Health Interoperability Task Force Report R Bhyat, S Ogunbiyi, M Anderson, O Bhattacharyya, C Chandrasena, ... Canada Health Infoway, 2024 | | 2024 |
| More Than a Eureka Moment: Undergraduate Students' Reflective Understanding of Science Inquiry in a Citizen Science Project. S Becker, D Clark, M Gupta, S Kannappan, B Wong, ... Alberta Science Education Journal 48 (1), 2022 | | 2022 |
| Identification of potential genetic drivers of Methotrexate (MTX) resistance in Atypical Teratoid Rhabdoid Tumours (ATRT) through a genome-wide RNAi screen S Kannappan, M Gupa, SM Kang, AS Tran, SS Thakur, M Jain, ... Neuro-Oncology 23 (Supplement_1), i3-i3, 2021 | | 2021 |
| Discovery and validation of a cross-platform 21-gene prognostic signature in neuroblastoma. M Gupta, SN Kannappan, A Narendran, P Bose Journal of Clinical Oncology 39 (15_suppl), 10035-10035, 2021 | | 2021 |
| Radiotherapy for Inflammatory Breast Cancer (IBC) in the Modern Multi-Modality Treatment Era: A Provincial Retrospective Review Over 12 Years S Kannappan, R Arora, T Phan American Journal of Biomedical Science and Research 12 (4), 384-389, 2021 | | 2021 |
| Examining Cannabis Usage and Cannabis-Related Information Sourcing for Disease Management in Clinical Oncology S Kannappan, J Ddamba, K Martell, R Arora, R Sinha Radiotherapy and Oncology 150, S23, 2020 | | 2020 |
| Comparison of Data Presence and Readability of Synoptic and Dictated Reports of Initial Consultations for Radiation Therapy: A Retrospective Review S Kannappan, R Arora, R Arora, R Sinha Radiotherapy and Oncology 150, S66, 2020 | | 2020 |
| Engaging Youth in Citizen Science: How Can We Determine What Learning Takes Place? S Becker, D Clark, B Wong, S Kannappan, M Gupta 2020 Conference of the Canadian Society for the Study of Education, 2020 | | 2020 |
| The Effect of CALM3, PRKCB, SCH1 and SHC2 Expression on Low-Grade Glioma Prognosis A Wang, J Wu, R Boss, C Ursu, A Bukhari, M Gupta, S Kannappan | | 2020 |
| Targeting Neurotrophic Receptor Tyrosine Kinase (NTRK) Fusion Structural Homologs in Refractory Pediatric Acute Lymphoblastic Leukemia (ALL) S Tran, M Gupta, S Kannappan, C Zhang, A Narendran Blood 134, 3882, 2019 | | 2019 |
| Impact of the addition of bevacizumab (Bev) to chemotherapy on survival in metastatic colorectal cancer (MCRC): A real-world population-based analysis. SN Kannappan, RK Arora, WY Cheung Journal of Clinical Oncology 37 (15_suppl), e18215-e18215, 2019 | | 2019 |
| Targeting LIN28 regulated pathways in novel therapeutics development for CNS Atypical teratoid/rhabdoid tumor (CNS ATRT) NA Kannappan S, Gupta M, Zhang C, Hoffman B, Chi S, Hanson D Neuro-Oncology 21 (Supplement_2), Page ii66, 2019 | | 2019 |
| Is Radiation Therapy Dose Escalation for Inflammatory Breast Cancer (IBC) Still Required with Modern Multi-Modality Treatment: A Multi-Institution Retrospective Review, 2000-2011 R Arora, S Kannappan, T Phan International Journal of Radiation Oncology, Biology, Physics 102 (3), e566-e567, 2018 | | 2018 |
| Discussions on the new molecular formula and new molecular entity definitions of pharmaceutical innovation M Gupta, S Kannappan Pharmaceutical Patent Analyst 7 (6), 235-239, 2018 | | 2018 |
Mehul GuptaUniversity of Calgary在 ucalgary.ca 的电子邮件经过验证
